Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 1, 2024
Event: Entry into a Material Definitive Agreement involving the issuance of Senior Secured Original Issue Discount Convertible Promissory Notes.
Key Financial Metrics and Transaction Details
- Gross Proceeds Raised: $1,250,000
- Aggregate Principal Amount of Notes: $1,541,666
- Interest Rate: 8% per annum (increases to 22% or maximum permitted by law upon Event of Default)
- Maturity Date: July 30, 2025
- Initial Conversion Price: $0.684 per share (subject to a $0.30 floor price)
- Prepayment Penalty: 125% of the principal amount being prepaid (25% premium)
- Use of Proceeds: Working capital and general corporate purposes
- Collateral: First priority security interest in company assets
Material Changes and Terms
The filing details a new debt financing arrangement not present in prior periods. Key structural terms include:
- Automatic Price Adjustment: The conversion price may automatically decrease to the "Market Conversion Price" on specific adjustment dates (30, 60, 90, 120, or 180 days post-registration effectiveness) if the current conversion price is higher.
- Default Consequences: Upon an uncured Event of Default, the interest rate increases significantly, and a "Mandatory Default Amount" becomes payable immediately.
- Beneficial Ownership Limitations: Investors are limited to beneficial ownership of 4.99% of outstanding common stock, increasing to 9.99% after 61 days with notice. Total issuance is capped at 19.9% of outstanding shares to comply with NYSE American rules.
- Shareholder Approval: The Company must file a proxy statement within 30 days and hold a special shareholder meeting within 90 days to approve the issuance of shares exceeding the 19.9% cap.
Guidance, Risks, and Contingencies
- Registration Rights: The Company is obligated to file a registration statement within 10 trading days and have it declared effective within 60 days to allow investors to resell conversion shares.
- Liquidity Risk: The debt is secured by a first priority security interest, which may limit future borrowing capacity against the same assets.
- Dilution Risk: Conversion of notes could result in significant dilution to existing shareholders, subject to the 19.9% cap and shareholder approval for excess shares.
- Unregistered Sale: The notes were sold under Section 4(a)(2) of the Securities Act and are not registered; they cannot be resold without registration or an exemption.
Investor Verification Checklist
- Verify the current market price of cbdMD common stock relative to the $0.684 conversion price and the $0.30 floor.
- Confirm the timeline for the upcoming special shareholder meeting required for excess share issuance.
- Review the Security Agreement (Exhibit 10.2) to understand the specific assets pledged as collateral.
- Monitor the filing of the registration statement for the conversion shares within the required 10-day window.
- Assess the company's ability to service the 8% interest and potential 25% prepayment premium given current cash flow.